Drugs / G-CSF
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00952237 Background | Jan 2003 → Apr 2011 | Hodgkins lymphoma, leukemia, non-Hodgkin lymphoma, plasma cell myeloma | Dartmouth-Hitchcock Medical Center | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | “G-CSF will be started (5mcg/kg/d) on Day #7 and will be given each morning.” NCT00952237 ↗ |